326 related articles for article (PubMed ID: 16819631)
1. CD4 regulatory T cells in human cancer pathogenesis.
Knutson KL; Disis ML; Salazar LG
Cancer Immunol Immunother; 2007 Mar; 56(3):271-85. PubMed ID: 16819631
[TBL] [Abstract][Full Text] [Related]
2. Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancers.
Knutson KL
Future Oncol; 2006 Jun; 2(3):379-89. PubMed ID: 16787118
[TBL] [Abstract][Full Text] [Related]
3. Immune regulation in tumor-bearing hosts.
Baecher-Allan C; Anderson DE
Curr Opin Immunol; 2006 Apr; 18(2):214-9. PubMed ID: 16464567
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells in cancer.
Mougiakakos D; Choudhury A; Lladser A; Kiessling R; Johansson CC
Adv Cancer Res; 2010; 107():57-117. PubMed ID: 20399961
[TBL] [Abstract][Full Text] [Related]
5. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
7. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
8. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes.
Mor A; Luboshits G; Planer D; Keren G; George J
Eur Heart J; 2006 Nov; 27(21):2530-7. PubMed ID: 16954132
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
[TBL] [Abstract][Full Text] [Related]
10. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
Chi LJ; Wang HB; Zhang Y; Wang WZ
J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases.
Zheng MH; Gu DN; Braddock M; Leishman AJ; Jin C; Wen JS; Gong YW; Chen YP
Expert Opin Ther Targets; 2008 Mar; 12(3):313-26. PubMed ID: 18269341
[TBL] [Abstract][Full Text] [Related]
12. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
13. Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Chi LJ; Wang HB; Wang WZ
J Peripher Nerv Syst; 2008 Mar; 13(1):54-63. PubMed ID: 18346231
[TBL] [Abstract][Full Text] [Related]
14. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
15. Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance.
Yong Z; Chang L; Mei YX; Yi L
Transpl Immunol; 2007 Feb; 17(2):120-9. PubMed ID: 17306743
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells: from bench to bedside.
Jiang S
Int Immunopharmacol; 2009 May; 9(5):515-7. PubMed ID: 19272465
[TBL] [Abstract][Full Text] [Related]
17. Antigen-induced regulatory T cells in HBV chronically infected patients.
Barboza L; Salmen S; Goncalves L; Colmenares M; Peterson D; Montes H; Cartagirone R; Gutiérrez Mdel C; Berrueta L
Virology; 2007 Nov; 368(1):41-9. PubMed ID: 17643462
[TBL] [Abstract][Full Text] [Related]
18. CD8+ regulatory T cells-A distinct T-cell lineage or a transient T-cell phenotype?
Aandahl EM; Torgersen KM; Taskén K
Hum Immunol; 2008 Nov; 69(11):696-9. PubMed ID: 18817824
[TBL] [Abstract][Full Text] [Related]
19. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
Jiang S; Tsang J; Lechler RI
Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
[TBL] [Abstract][Full Text] [Related]
20. Regulating regulatory T cells.
Le NT; Chao N
Bone Marrow Transplant; 2007 Jan; 39(1):1-9. PubMed ID: 17057725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
